Page last updated: 2024-09-03

umifenovir and 2019 Novel Coronavirus Disease

umifenovir has been researched along with 2019 Novel Coronavirus Disease in 71 studies

Research

Studies (71)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	71 (100.00)	2.80

Authors

Authors	Studies
Chen, L; Fu, W; He, XL; Liang, MY; Ma, WL; Wang, XR; Xue, YE; Yang, BH; Zhang, JC; Zhou, Q; Zhou, YY	1
Chen, N; Jiang, Y; Lin, R; Wang, X; Zhang, S	1
Atam, V; Bhosale, V; Faridi, M; Fatima, J; Ghosh, N; Khan, H; Khan, ZA; Kundu, TK; Majumdar, N; Mishra, PR; Negi, MPS; Ramachandran, R; Rath, SK; Reddy, H; Sharma, S; Shukla, V; Singh, V; Srivastava, AK; Srivastava, M; Tripathi, CB; Tripathi, RK	1
Kosyakov, DS; Lebedev, AT; Shavrina, IS; Sypalov, SA; Ul'yanovskii, NV; Varsegov, IS	1
Huang, LY; Lei, YH; Li, S; Wang, DC; Wei, J; Yu, M	1
Armen, RS; Freidel, MR	1
Guo, Y; He, Y; Jiang, P; Wu, SH; Zhu, T	1
Agarwal, A; Ambrose, JM; Gandhamaneni, SH; Gangadharan, S; Jayaraman, S; Kullappan, M; Nakkella, AK; Patil, S; Rajajagadeesan, A; Surapaneni, KM; Veeraraghavan, VP	1
Areekkara, AN; Benny, F; Jayaprakashkamath, A; Mani, RP; Murali, M; Nair, B; Nath, LR; Presanna, AT; Suresh, D	1
Kang, Y; Shi, Y; Xu, S	1
Chen, F; Chen, X; Lu, Y; Wang, Z; Zhang, W	1
Dong, L; Gao, J; Hu, S	1
Wang, Y; Zhu, LQ	1
Deng, L; Hong, Z; Li, C; Li, X; Liu, X; Xia, J; Zeng, Q; Zhang, H	1
Duan, Y; Zhou, C; Zhu, HL	1
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM	1
Chen, C; Lu, J; Lu, Z; Xu, T; Xue, Y; Yang, G; Zha, T; Zhu, Z	1
Costanzo, M; De Giglio, MAR; Roviello, GN	1
Ahsan, W; Alhazmi, HA; Bratty, MA; Javed, S; Najmi, A	1
Li, J; Liu, B; Song, D; Zhang, L	1
Huang, J; Lian, N; Lin, Q; Lin, S; Xie, H; Zhao, J	1
Vankadari, N	1
Jiang, J; Lin, S; Ruan, J; Wang, L; Xu, X; Ye, H	1
Chen, C; Chen, M; Cheng, C; Chi, Y; Hu, Z; Huang, S; Jiao, D; Liang, C; Liu, Y; Lv, Y; Sun, W; Wei, H; Yi, Y; Zhang, X	1
Chang, J; Hu, B; Li, YN; Mao, L; Miao, XP; Peng, B; Peng, W; Wan, Y; Wang, WJ; Wang, YL; Zhang, JN; Zhang, YS; Zhou, YF	1
Chen, K; Couban, RJ; Du, X; Gong, X; Guyatt, G; He, N; Ibrahim, QI; Li, X; Li, Y; Liu, F; Liu, J; Liu, W; Shen, N; Tang, Q; Wu, Z; Xu, X; Ye, Z; Ying, Y; Zhai, S; Zhang, Q; Zhang, Y; Zhou, P	1
Amore, A; Bimonte, S; Cascella, M; Celentano, E; Crispo, A; Cuomo, A	1
Chen, D; Dong, L; Pan, X; Peng, C; Yang, L	1
Cai, C; Deng, Y; Hu, ZY; Huang, K; Huang, Y; Wang, X; Wang, Y; Xie, J; Xie, Y; Xu, D; Zang, J; Zhan, T; Zheng, F	1
Chen, V; Fish, EN; Kollmann, TR; Shannon, CP; Tebbutt, SJ; Wang, X; Wang, ZH; Wei, XS; Xiang, X; Zhou, Q	1
Hu, S; Hu, Z; Ke, C; Li, W; Liu, J; Liu, W; Wang, S; Yang, C; Yue, D	1
Li, C; Ren, L; Wang, L	1
Cleland, E; Giovane, RA; Henderson, CE; Rezai, S	1
Zhao, J; Zhou, J; Zhou, X	1
Cai, W; Cao, Y; Chen, X; Hu, F; Li, F; Li, L; Li, Y; Lin, W; Ou, X; Tang, X; Wen, C; Xie, Z	1
Cai, J; Lang, G; Ni, Q; Shen, X; Sheng, J; Su, J; Wu, W; Xu, K; Zhao, H; Zhu, B	1
Brun, P; Dubois, J; Dulière, V; Julien, T; Lina, B; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O; Traversier, A	1
Li, Z; Liu, Y; Wang, D	1
Cui, M; Guo, Y; Hong, P; Hou, Z; Liu, F; Lu, Y; Qian, X; Qiu, F; Song, P; Tong, G; Wan, D; Wang, N; Wang, S; Wang, X; Xu, Y; Yu, H; Zhan, Y; Zheng, Z; Zhu, L; Zou, X	1
Bellutti-Enders, F; Hartmann, K; Jamiolkowski, D; Leuppi-Taegtmeyer, A; Manjaly Thomas, ZR; Scherer Hofmeier, K; Steveling-Klein, E	1
Chen, C; Chen, Y; Hu, F; Liu, J; Song, J; Song, Y; Tang, X; Ye, M; Yin, G; Zhang, Y	1
Cheng, X; Guan, X; Jin, L; Liang, L; Liao, X; Liu, Y; Shi, Y; Song, L; Su, R; Wang, J; Xin, S; Xing, L; Xu, X; Yang, F; Yu, R; Yu, Y; Zhang, D; Zhou, W; Zhu, B	1
Al-Yamani, MJ; Asdaq, SMB; Jomah, S	1
Ijaz, M; Khan, M; Kharaba, ZJ; Murtaza, G; Shamim, S	1
Bao, S; Deng, Z; Sun, G; Wang, X; Xie, P; Zhao, M; Zhou, Y	1
Chen, F; Chen, Y; Fang, Q; Hu, S; Jiang, J; Liang, T; Lu, S; Sheng, J; Wei, N; Wu, L; Zheng, S; Zhou, J	1
Choudhary, S; Silakari, O	1
Guo, F; Li, S; Liu, C; Shang, D; Taleb, SJ; Tong, M	1
Luo, S; Tian, M; Wang, L; Xia, W; Zeng, Y; Zha, Y; Zhang, K; Zhang, X	1
Aktas, A; Ataseven, H; Sayin, K; Taskin, AH; Tuzun, B	1
Deng, M; Hu, Y; Jiang, L; Luo, X; Pan, L; Wang, M; Wu, T; Xia, Z; Yang, X; You, Y; Zuo, Z	1
Chen, R; Chen, S; Gao, W; Guo, Q; He, Y; Hua, J; Jin, L; Li, Q; Lu, J; Wang, F; Wang, K; Wang, S; Wu, X; Yan, Q	1
Mishra, SK; Tripathi, T	1
Chen, X; Huang, Z; Kuang, Y; Liu, C; Liu, P; Pan, P; Yin, M	1
Gao, Q; Liu, D; Ma, D; Song, C; Tan, J; Xu, C; Yuan, Y	1
Kumar, D; Trivedi, N; Verma, A	1
Li, K; Li, X; Li, Y; Li, Z; Liu, C; Luo, B; Tan, W; Wang, X; Wu, Y; Xiong, W; Yin, H; Zhu, Y	1
Fish, EN; Hanna, BS; He, X; MacArthur, MR; Wang, ZH; Wei, X; Xiang, X; Zarin, P; Zhou, Q	1
Chen, J; Liu, D; Lu, H; Yin, L; Zhang, L	1
Wen, S; Xu, X; Yadav, AK; Yu, L	1
Chen, YZ; Huang, M; Ma, J; Wu, HY; Zhang, LS	1
Cai, L; Cao, Y; Fu, M; Guo, X; Hong, L; Yi, G; Ying, P; Zhang, Y	1
Chukhliaev, PV; Garbuzov, AA; Khavkina, DA; Ploskireva, AA; Ruzhentsova, TA	1
Alotaibi, NH; Bokharee, N; Khan, YH; Khokhar, A; Mallhi, TH; Rasheed, M	1
Bulgakova, VA; Leneva, IA; Pshenichnaya, NY	1
Keykhaei, M; Mansouri, ES; Rahimzadeh, H; Razeghi, E; Zivari, E	1
Bohan, Y; Hongmei, Y; Jie, X; Kuikui, Z; Ping, F; Rui, M	1
Chen, G; Ding, T; Hong, Z; Li, X; Liang, S; Liu, X; Shang, Y; Wei, L; Wu, M; Xia, J; Zou, Z	1
Irani, AH; Sleigh, J; Steyn-Ross, DA; Steyn-Ross, ML; Voss, L	1
Bao, Y; Chen, Z; Ding, J; Feng, Y; Guan, H; Li, H; Liu, W; Wang, X; Zhou, Z	1
Ding, G; Heng, Y; Hou, H; Hu, Q; Hu, Z; Huang, L; Li, C; Liu, R; Ma, M; Wei, T; Xing, W; Xu, X; Yang, L; Zhao, Y; Zhao, Z; Zhou, X	1

Reviews

23 review(s) available for umifenovir and 2019 Novel Coronavirus Disease

Article	Year
Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019. Journal of medical virology, 2022, Volume: 94, Issue:4 Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Indoles; Lopinavir; Ritonavir; SARS-CoV-2; Sulfides; Treatment Outcome	2022
Identification of Kaempferol as Viral Entry Inhibitor and DL-Arginine as Viral Replication Inhibitor from Selected Plants of Indian Traditional Medicine against COVID-19: An Current computer-aided drug design, 2023, Volume: 19, Issue:4 Topics: Antiviral Agents; Arginine; COVID-19; Glycoproteins; HEK293 Cells; Humans; Kaempferols; Medicine, Traditional; Molecular Docking Simulation; Molecular Dynamics Simulation; RNA-Dependent RNA Polymerase; SARS-CoV-2; Virus Internalization	2023
Arbidol: The current demand, strategies, and antiviral mechanisms. Immunity, inflammation and disease, 2023, Volume: 11, Issue:8 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; COVID-19; Humans; Influenza, Human	2023
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019. World journal of pediatrics : WJP, 2020, Volume: 16, Issue:3 Topics: Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; China; Chloroquine; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Male; Pandemics; Pharmaceutical Services; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Treatment Outcome	2020
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 2020, May-12, Volume: 323, Issue:18 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment	2020
Treatment of SARS-CoV-2: How far have we reached? Drug discoveries & therapeutics, 2020, May-06, Volume: 14, Issue:2 Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferon-alpha; Interferon-beta; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2	2020
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020, 07-06, Volume: 192, Issue:27 Topics: Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Evidence-Based Medicine; Humans; Hydroxychloroquine; Indoles; Influenza, Human; Lopinavir; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2	2020
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome	2020
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China. Virus research, 2020, Volume: 286 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Indoles; Interferons; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis	2020
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection. Virus research, 2020, Volume: 286 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Teicoplanin	2020
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review. Reviews in medical virology, 2020, Volume: 30, Issue:5 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Drug Repositioning; Esters; Gabexate; Gene Expression Regulation; Guanidines; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2020
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics. Journal of infection and public health, 2020, Volume: 13, Issue:10 Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antimalarials; Antiviral Agents; Betacoronavirus; Biomedical Research; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Drug Development; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2	2020
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities. The Journal of allergy and clinical immunology, 2020, Volume: 146, Issue:4 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Hypersensitivity; Humans; Immunity, Innate; Immunologic Factors; Indoles; Infliximab; Interleukin 1 Receptor Antagonist Protein; Nitriles; Pandemics; Pneumonia, Viral; Pyrazines; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index	2020
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review. Journal of infection and public health, 2020, Volume: 13, Issue:9 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2	2020
Potential strategies for combating COVID-19. Archives of virology, 2020, Volume: 165, Issue:11 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Indoles; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Severity of Illness Index; Viral Vaccines	2020
A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019. Medicine, 2020, Jul-24, Volume: 99, Issue:30 Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Indoles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
Traditional Chinese Medicine as Potential Therapy for COVID-19. The American journal of Chinese medicine, 2020, Volume: 48, Issue:6 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Combinations; Drugs, Chinese Herbal; Humans; Indoles; Janus Kinase Inhibitors; Lopinavir; Medicine, Chinese Traditional; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis. BMJ supportive & palliative care, 2021, Volume: 11, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antirheumatic Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Indoles; Lopinavir; Medicine, Chinese Traditional; Ritonavir; SARS-CoV-2; Treatment Outcome	2021
One year update on the COVID-19 pandemic: Where are we now? Acta tropica, 2021, Volume: 214 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Drug Combinations; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Indoles; Ivermectin; Lopinavir; Mutation; Pandemics; Phytotherapy; Plant Extracts; Pyrazines; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tinospora; Viral Zoonoses	2021
Possible treatment and strategies for COVID-19: review and assessment. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:23 Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiparasitic Agents; Antiviral Agents; Cannabinoids; Chloroquine; Complement Inactivating Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Pyrazines; Ritonavir; SARS-CoV-2; Teicoplanin; Tetracyclines; Thiazoles	2020
Antiviral treatment in COVID-19: which is the most promising?-a narrative review. Annals of palliative medicine, 2021, Volume: 10, Issue:1 Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles	2021
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials. Expert review of anti-infective therapy, 2021, Volume: 19, Issue:10 Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Chloroquine; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Intensive Care Units; Length of Stay; Lopinavir; Methylprednisolone; Observational Studies as Topic; Patient Admission; Pyrazines; Ritonavir; SARS-CoV-2; Survival Rate	2021
[Umifenovir and coronavirus infections: a review of research results and clinical practice]. Terapevticheskii arkhiv, 2020, Dec-26, Volume: 92, Issue:11 Topics: Animals; Antiviral Agents; Coronavirus Infections; COVID-19; Humans; Indoles; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2020

Trials

3 trial(s) available for umifenovir and 2019 Novel Coronavirus Disease

Article	Year
Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 115 Topics: Adult; Antiviral Agents; COVID-19; Double-Blind Method; Humans; Indoles; SARS-CoV-2; Sulfides; Treatment Outcome	2022
Interferon-α2b Treatment for COVID-19. Frontiers in immunology, 2020, Volume: 11 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; China; Cohort Studies; Comorbidity; Coronavirus Infections; COVID-19; Cytokines; Drug Therapy, Combination; Female; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pandemics; Pneumonia, Viral; Sex Factors	2020
Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial. Trials, 2020, Dec-04, Volume: 21, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Case-Control Studies; China; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Indoles; Interleukin-17; Lopinavir; Middle Aged; Ribavirin; Ritonavir; Safety; SARS-CoV-2; Th17 Cells; Treatment Outcome	2020

Other Studies

45 other study(ies) available for umifenovir and 2019 Novel Coronavirus Disease

Article	Year
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study. Current medical science, 2021, Volume: 41, Issue:6 Topics: Adult; Aged; Antiviral Agents; China; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Female; Hospitalization; Humans; Indoles; Interferons; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pandemics; Retrospective Studies; Risk Factors; RNA, Viral; SARS-CoV-2; Time Factors; Virus Shedding	2021
Efficacy analysis of Arbidol treatment in patients with 2019 novel coronavirus pneumonia: a retrospective cohort study. Annals of palliative medicine, 2021, Volume: 10, Issue:10 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; COVID-19; Humans; Indoles; Retrospective Studies; SARS-CoV-2	2021
Antiviral drug Umifenovir (Arbidol) in municipal wastewater during the COVID-19 pandemic: Estimated levels and transformation. The Science of the total environment, 2022, Jan-20, Volume: 805 Topics: Antiviral Agents; COVID-19; Humans; Indoles; Pandemics; SARS-CoV-2; Wastewater; Water Pollutants, Chemical	2022
Modeling the Structure-Activity Relationship of Arbidol Derivatives and Other SARS-CoV-2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein. Journal of chemical information and modeling, 2021, 12-27, Volume: 61, Issue:12 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; COVID-19; Hepatitis C, Chronic; Humans; Indoles; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Virus Internalization	2021
A rare case of drug-induced bradycardia associated with the just low dose use of methylprednisolone in a child with COVID-19. Journal of medical virology, 2022, Volume: 94, Issue:4 Topics: Anti-Inflammatory Agents; Antiviral Agents; Bradycardia; Child; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Indoles; Male; Methylprednisolone; SARS-CoV-2; Sulfides	2022
Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach. Journal of infection and public health, 2022, Volume: 15, Issue:11 Topics: Antiviral Agents; COVID-19; Drug Repositioning; Fidaxomicin; Humans; Molecular Docking Simulation; Rifabutin; RNA-Dependent RNA Polymerase; SARS-CoV-2	2022
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Bioscience trends, 2020, Mar-16, Volume: 14, Issue:1 Topics: Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Indoles; Lopinavir; Male; Middle Aged; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2; Young Adult	2020
Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug discoveries & therapeutics, 2020, Volume: 14, Issue:1 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Studies as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Humans; Indoles; Pandemics; Pneumonia, Viral; Pyrazines; Ribonucleotides; SARS-CoV-2; Virus Replication	2020
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study. The Journal of infection, 2020, Volume: 81, Issue:1 Topics: Administration, Oral; Adult; Antiviral Agents; Cohort Studies; Coronavirus Infections; COVID-19; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indoles; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; Tomography, X-Ray Computed	2020
Advance of promising targets and agents against COVID-19 in China. Drug discovery today, 2020, Volume: 25, Issue:5 Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins	2020
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19. The Journal of infection, 2020, Volume: 81, Issue:1 Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Female; Humans; Indoles; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2; Viral Load	2020
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus. Current medicinal chemistry, 2020, Volume: 27, Issue:27 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2	2020
Case Report: Viral Shedding for 60 Days in a Woman with COVID-19. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Acids, Carbocyclic; Aged; Betacoronavirus; China; Coronavirus Infections; COVID-19; Cyclopentanes; Extracorporeal Membrane Oxygenation; Female; Guanidines; Humans; Indoles; Lung; Moxifloxacin; Pandemics; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Virus Shedding	2020
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:7 Topics: Aged; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Length of Stay; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Treatment Outcome	2020
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein. International journal of antimicrobial agents, 2020, Volume: 56, Issue:2 Topics: Antiviral Agents; Betacoronavirus; Biopolymers; Coronavirus Infections; COVID-19; Humans; Indoles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2020
Quadruple therapy for asymptomatic COVID-19 infection patients. Expert review of anti-infective therapy, 2020, Volume: 18, Issue:7 Topics: Asymptomatic Infections; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases. Journal of neurovirology, 2020, Volume: 26, Issue:3 Topics: Adolescent; Adult; Antiviral Agents; Betacoronavirus; China; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Female; Humans; Indoles; Male; Methylprednisolone; Olfaction Disorders; Pandemics; Pneumonia, Viral; SARS-CoV-2; Taste Disorders; Treatment Outcome; Vitamin B 12	2020
Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission: A Preliminary Report of a Retrospective Cohort Study. Current medical science, 2020, Volume: 40, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Family; Female; Health Personnel; Humans; Indoles; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; Pneumonia, Viral; Post-Exposure Prophylaxis; Regression Analysis; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome	2020
Treatment strategies of hospitalized patients with coronavirus disease-19. Aging, 2020, 06-17, Volume: 12, Issue:12 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Female; gamma-Globulins; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Indoles; Interferons; Lopinavir; Male; Middle Aged; Oxygen; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2	2020
Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals. Frontiers in public health, 2020, Volume: 8 Topics: Adult; Antiviral Agents; COVID-19; Female; Health Personnel; Hospitalization; Humans; Indoles; Male; Risk Factors; SARS-CoV-2	2020
Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report. BMC infectious diseases, 2020, Jul-11, Volume: 20, Issue:1 Topics: Adult; Antibody Formation; Antiviral Agents; B-Lymphocytes; Betacoronavirus; Coronavirus Infections; COVID-19; Hospitals; Humans; Immunity, Humoral; Indoles; Male; Nucleotidyltransferases; Pandemics; Patient Discharge; Pneumonia, Viral; Recurrence; SARS-CoV-2; Ventilators, Mechanical	2020
Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019. Journal of medical virology, 2021, Volume: 93, Issue:2 Topics: Adult; Anal Canal; Antiviral Agents; C-Reactive Protein; Chloroquine; COVID-19; COVID-19 Testing; Female; Hospitalization; Humans; Indoles; Intensive Care Units; Lymphopenia; Male; Middle Aged; Oseltamivir; Pharynx; Retrospective Studies; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Viral Load	2021
Infection of severe acute respiratory syndrome coronavirus 2 in a patient with AIDS. AIDS (London, England), 2020, 08-01, Volume: 34, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Indoles; Interferon-alpha; Lopinavir; Lung; Male; Pandemics; Pneumonia, Viral; Radiography, Thoracic; Ritonavir; SARS-CoV-2; Sputum; Tomography, X-Ray Computed; Treatment Outcome	2020
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Antiviral research, 2020, Volume: 181 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Antagonism; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells	2020
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients. Cell host & microbe, 2020, 09-09, Volume: 28, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Betacoronavirus; Child; China; Cohort Studies; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospital Mortality; Host Microbial Interactions; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Length of Stay; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome; Young Adult	2020
Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019. The clinical respiratory journal, 2020, Volume: 14, Issue:11 Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Female; Hospitalization; Humans; Immunoglobulins; Indoles; Interferons; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Retrospective Studies; Risk Factors; SARS-CoV-2; Time Factors; Virus Shedding	2020
Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hospitalization; Humans; Indoles; Interferons; Length of Stay; Lopinavir; Male; Middle Aged; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult	2020
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder. Journal of affective disorders, 2020, 12-01, Volume: 277 Topics: Antibodies, Viral; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Bipolar Disorder; Brain; Chest Pain; China; Clinical Laboratory Techniques; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Dyspnea; Fever; Glucocorticoids; Humans; Indoles; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Olanzapine; Pandemics; Pharyngitis; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2	2020
Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19. Virus research, 2020, Volume: 289 Topics: Algorithms; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Biological Availability; Coronavirus Infections; COVID-19; Drug Design; Humans; Indoles; Molecular Docking Simulation; Molecular Structure; Pandemics; Peptide Hydrolases; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Binding; Protein Domains; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Virus Attachment; Virus Internalization; Virus Replication	2020
The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19. Complementary therapies in medicine, 2020, Volume: 52 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Indoles; Lopinavir; Medicine, Chinese Traditional; Methylprednisolone; Middle Aged; Moxifloxacin; Noninvasive Ventilation; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Qi; Ritonavir; SARS-CoV-2	2020
How do arbidol and its analogs inhibit the SARS-CoV-2? Bratislavske lekarske listy, 2020, Volume: 121, Issue:10 Topics: Betacoronavirus; Binding Sites; Coronavirus Infections; COVID-19; Humans; Indoles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2020
Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID-19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series. Virology journal, 2020, 10-23, Volume: 17, Issue:1 Topics: Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Indoles; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2	2020
A retrospective comparison of drugs against COVID-19. Virus research, 2021, Volume: 294 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunoglobulin M; Indoles; Length of Stay; Lopinavir; Male; Middle Aged; Oseltamivir; Retrospective Studies; Ritonavir; SARS-CoV-2; Young Adult	2021
Clinical characteristics and viral shedding kinetics of 38 asymptomatic patients with coronavirus disease 2019: A retrospective observational study. Medicine, 2020, Dec-18, Volume: 99, Issue:51 Topics: Adolescent; Adult; Asymptomatic Infections; Child; China; COVID-19; Female; Humans; Indoles; Infant; Male; Medicine, Chinese Traditional; Middle Aged; Radiography, Thoracic; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult	2020
Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities. Viruses, 2020, 12-30, Volume: 13, Issue:1 Topics: Administration, Inhalation; Antiviral Agents; Biomarkers; C-Reactive Protein; CD8-Positive T-Lymphocytes; China; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Cytokines; Drug Therapy, Combination; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Interleukin-10; Interleukin-6; Lung; SARS-CoV-2	2020
Can we use hydroxychloroquine to treat COVID-19 now? International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Indoles; Interferon-alpha; Lopinavir; Ritonavir; SARS-CoV-2; Uncertainty	2021
Thoughts on Traditional Chinese Medicine Treatment of Novel Coronavirus Pneumonia Based on Two Cases. Chinese journal of integrative medicine, 2021, Volume: 27, Issue:5 Topics: Adult; Body Temperature; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drugs, Chinese Herbal; Ephedra sinica; Female; Fever; Glycyrrhiza; Humans; Indoles; Male; Medicine, Chinese Traditional; Middle Aged; Phytotherapy; Pneumonia, Viral; Radiography, Thoracic; SARS-CoV-2	2021
Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review). International journal of molecular medicine, 2021, Volume: 47, Issue:4 Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Cardiovascular Diseases; Chloroquine; COVID-19; Host-Pathogen Interactions; Humans; Indoles; Molecular Targeted Therapy; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization	2021
[Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients]. Voprosy virusologii, 2021, 03-07, Volume: 66, Issue:1 Topics: Acetylcysteine; Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Atrial Fibrillation; Azithromycin; Cohort Studies; Comorbidity; Coronary Disease; COVID-19; COVID-19 Drug Treatment; Dabigatran; Disseminated Intravascular Coagulation; Female; Humans; Hypertension; Indoles; Interferon alpha-2; Intracranial Arteriosclerosis; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; SARS-CoV-2; Severity of Illness Index; Survival Analysis	2021
COVID-19 progression in kidney transplant recipients: a single-center case series. CEN case reports, 2021, Volume: 10, Issue:4 Topics: Acute Kidney Injury; Adult; Antimalarials; Antiviral Agents; COVID-19; Disease Progression; Female; Glucocorticoids; Hospital Mortality; Humans; Hydroxychloroquine; Immunosuppressive Agents; Indoles; Intensive Care Units; Iran; Kidney Transplantation; Male; Middle Aged; Outcome Assessment, Health Care; Prednisolone; Risk Factors; SARS-CoV-2; Transplant Recipients	2021
Beneficial effect of Arbidol in the management of COVID-19 infection. Aging, 2021, 04-03, Volume: 13, Issue:7 Topics: Aged; Antiviral Agents; China; COVID-19; COVID-19 Drug Treatment; Female; Fibrin Fibrinogen Degradation Products; Humans; Indoles; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Treatment Outcome	2021
Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients. Frontiers in immunology, 2021, Volume: 12 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Viral; Antibody Formation; COVID-19; COVID-19 Drug Treatment; Female; Humans; Indoles; Lopinavir; Male; Middle Aged; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2021
The molecular dynamics of possible inhibitors for SARS-CoV-2. Journal of biomolecular structure & dynamics, 2022, Volume: 40, Issue:20 Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; COVID-19; Humans; Hydroxychloroquine; Molecular Dynamics Simulation; Protein Binding; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2022
Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy. Medicine, 2021, Jul-16, Volume: 100, Issue:28 Topics: Aged; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index	2021
Arbidol is associated with increased in-hospital mortality among 109 patients with severe COVID-19: A multicenter, retrospective study. Journal of global health, 2021, Volume: 11 Topics: Aged; China; COVID-19; COVID-19 Drug Treatment; Hospital Mortality; Humans; Indoles; Retrospective Studies; Severity of Illness Index	2021